Dr Michael J Grahl, MD | |
430 E Division St, Fond Du Lac, WI 54935-4560 | |
(920) 926-4600 | |
Not Available |
Full Name | Dr Michael J Grahl |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 430 E Division St, Fond Du Lac, Wisconsin |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306208921 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 75162-20 (Wisconsin) | Primary |
208D00000X | General Practice | 35.135979 (Ohio) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Dr Michael J Grahl, MD 430 E Division St, Emergency Department, Fond Du Lac, WI 54935-4560 Ph: (920) 926-4600 | Dr Michael J Grahl, MD 430 E Division St, Fond Du Lac, WI 54935-4560 Ph: (920) 926-4600 |
News Archive
The U.S. Food and Drug Administration (FDA) has sent a warning letter to Procter & Gamble for making unlawful claims about its Vicks Early Defense Foaming Hand Sanitizer (Early Defense) product.
Executives from pharmaceutical companies and health care payer and provider organizations convened at the "Selling Pharmaceuticals in 2015" forum in Philadelphia to discuss mutually beneficial partnerships that, if implemented, could replace the traditional model of selling drugs on price, features and benefits with a new model that focuses on quantifying and communicating total value.
Adolescents in developed countries frequently use dietary supplements despite a lack of knowledge about possible harmful effects or drug interactions.
Hemosphere, Inc., a private medical device company, has completed a late round of venture capital financing totaling $9.3 million. The company has developed the HeRO® Vascular Access Device, which provides access for hemodialysis - the process of filtering waste products from blood when kidneys are in renal failure - similar to a conventional graft.
Seattle Genetics, Inc. today announced that the U.S. Food and Drug Administration has granted accelerated approval of ADCETRISTM for two indications: (1) the treatment of patients with Hodgkin lymphoma after failure of autologous stem cell transplant or after failure of at least two prior multi-agent chemotherapy regimens in patients who are not ASCT candidates, and (2) the treatment of patients with systemic anaplastic large cell lymphoma after failure of at least one prior multi-agent chemotherapy regimen.
› Verified 2 days ago
Ann M Cappellari, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 920-929-2300 | |
Mark S Kermgard, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 145 N Main St, Fond Du Lac, WI 54935 Phone: 920-926-8492 Fax: 920-926-8903 | |
Dr. Scott J Stellmacher, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 210 Wisconsin American Dr, Fond Du Lac, WI 54935 Phone: 920-907-7000 | |
Martha W Bauder, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 920-926-4600 | |
Matthew Murphy, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 920-929-2300 | |
Michelle C Pesek-mccoy, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 920-926-4600 |